- Okay Navigator will increase researcher productiveness by 20x¹, accelerating biomedical breakthroughs and outperforming main generalist LLMs
- Analyzes and visualizes multimodal affected person knowledge, plus unique entry to MOSAIC Window, a subset of the world’s largest spatial omics dataset in oncology
- Constructed by biologists, for biologists. Free to make use of for educational researchers.²
NEW YORK & PARIS–(BUSINESS WIRE)–Owkin, a number one agentic AI firm, has launched Okay Navigator, an AI-powered analysis co-pilot designed to revolutionize biomedical science. Okay Navigator is an agentic playground the place researchers can discover, refine, and validate hypotheses, accelerating the standard and tempo of their discoveries. With Okay Navigator, Owkin strikes nearer to its imaginative and prescient of creating the world’s first Organic Synthetic Superintelligence (BASI).
Okay Navigator is an agentic AI playground the place researchers can discover, refine, and validate hypotheses, accelerating the standard and pace of their discoveries by 20X.
A single pure language interface – Okay Navigator allows customers to discover and visualize knowledge, refine questions, and uncover insights with ease. It accelerates literature critiques throughout 26.5 million scientific articles, reveals unexplored and unpublished analysis areas, and delivers extra correct evaluation, drawing on 19 biomedical databases that includes 1000’s of sufferers.
Unique entry to cutting-edge spatial transcriptomic knowledge – It completely accesses and analyzes newly launched spatial multiomic knowledge at single cell decision from MOSAIC Window,³ a subset of the most important spatial omics dataset in oncology, offering researchers with insights and accuracy unmatched by every other AI co-pilot. MOSAIC knowledge is generated by prime tier tutorial universities throughout Europe and the US.
Superior efficiency – On duties associated to analyzing public datasets, Okay Navigator matches giant language fashions (together with reasoning fashions like 03 from OpenAI) and outperforms them in detecting cancer-related patterns.⁴
Free for the tutorial analysis neighborhood – Okay Navigator is free to tutorial researchers to strengthen the primary AI agentic biomedical collective intelligence. Owkin is working with world-leading establishments to form and repeatedly enhance it. The following replace of the product will embrace seamless collaboration, consequence sharing, and mission group, in addition to superior histology instruments for filtering, grouping, warmth mapping, and deeper digital pathology slide evaluation.
Reworking analysis past academia – Later this 12 months, Owkin will launch Okay Professional, an prolonged AI co-pilot that includes a collection of brokers to unravel complicated pharma challenges throughout knowledge exploration, drug discovery, and drug growth.
Thomas Clozel, MD, Owkin Co-founder and CEO, commented: “Over the previous century, we’ve made super progress in chemistry; progress that has solely accelerated with the assistance of AI. However biology is a special problem altogether: it’s too complicated for the human thoughts alone, with its huge networks of genes, cells, and interactions.
“To actually perceive illness and develop cures for unmet medical wants, we have to productize analysis by augmenting and accelerating discovery at each degree. That’s why we developed Okay Navigator. The final word intention for Okay is to curate giant language fashions and basis fashions with patient-level knowledge at scale, so we will transfer nearer to ground-truth biology and eventually seize its full complexity.”
Dr. Ingo Ringshausen, Principal Investigator at College School London & Guide Haematologist at College School London Hospital, stated, “After my first hands-on expertise with Okay Navigator, I used to be instantly struck by its distinctive ease of use. The potential influence for analysis groups is clear, specifically due to its sturdy multi-omics affected person knowledge exploration capabilities.”
Dr. Cécile Alanio, Deputy Director of Scientific Immunology Laboratory, Institut Curie, stated:“Okay Navigator is a tremendous product that provides us the autonomy we’ve been lacking to discover knowledge independently. It empowers researchers whereas enabling bioinformaticians to deal with extra complicated analytical challenges. The options are really spectacular, it permits us to get a really feel for the information – which is what I really like most about it.”
About Owkin
Owkin is an agentic AI firm on a mission to discover complicated biology to hurry up and scale analysis for the creation of recent therapies and diagnostics for sufferers. Owkin Okay, our AI co-pilot combines unparalleled entry to multimodal knowledge, cutting-edge AI to quantify biology and pioneering agentic AI to realize Organic Synthetic Superintelligence sooner or later.
References
- 20x productiveness is a median throughout numerous duties, for instance: producing a spatial transcriptomics plot takes on common 1 minute, in comparison with 3 days, and drug goal characterization (annotation) is on common 75% quicker with Okay in comparison with handbook strategies.
- Preliminary signup contains free entry to the beta model for a 6-month analysis interval. We’re at the moment restricted to a restricted variety of customers for the analysis interval of our beta model of Okay-Navigator. In the meanwhile, entry is out there to a small group of customers, and we’ve arrange a waitlist for everybody else serious about becoming a member of.
- MOSAIC is a worldwide initiative led by Owkin and uniting prime tutorial facilities (Charité – Universitätsmedizin Berlin, College of Pittsburgh, Institut Gustave Roussy, Lausanne College Hospital – CHUV, and Uniklinikum Erlangen), to create the world’s largest spatial omics and multimodal dataset in oncology and revolutionize therapeutic targets and biomarker discovery. MOSAIC Window is a 60-patient subset from the bigger MOSAIC dataset. This dataset is pseudonymized, pre-processed, and made out there to researchers via Okay Navigator.
- We benchmarked Okay-Navigator towards a subset of the general public benchmark LAB-Bench. On most duties, Okay-Navigator performs on par with all frontier LLMs examined, together with reasoning ones. Okay-Navigator reveals superiority on the oncogenic signature subtask. In oncogenic signature, fashions are requested to establish genes belonging to very particular gene units that behave in a sure manner in most cancers fashions.
Authorized discover
Sure potential customers of Owkin Okay could also be topic to anti-gift or anti-bribery laws primarily based on their career and jurisdiction. Owkin is accumulating all pertinent info from potential customers to make sure that anti-gifting and bribery legal guidelines are adopted throughout jurisdictions. Owkin reserves the precise to limit entry to sure customers who’re prohibited from accepting them underneath relevant laws.
Contacts
- Okay Navigator will increase researcher productiveness by 20x¹, accelerating biomedical breakthroughs and outperforming main generalist LLMs
- Analyzes and visualizes multimodal affected person knowledge, plus unique entry to MOSAIC Window, a subset of the world’s largest spatial omics dataset in oncology
- Constructed by biologists, for biologists. Free to make use of for educational researchers.²
NEW YORK & PARIS–(BUSINESS WIRE)–Owkin, a number one agentic AI firm, has launched Okay Navigator, an AI-powered analysis co-pilot designed to revolutionize biomedical science. Okay Navigator is an agentic playground the place researchers can discover, refine, and validate hypotheses, accelerating the standard and tempo of their discoveries. With Okay Navigator, Owkin strikes nearer to its imaginative and prescient of creating the world’s first Organic Synthetic Superintelligence (BASI).
Okay Navigator is an agentic AI playground the place researchers can discover, refine, and validate hypotheses, accelerating the standard and pace of their discoveries by 20X.
A single pure language interface – Okay Navigator allows customers to discover and visualize knowledge, refine questions, and uncover insights with ease. It accelerates literature critiques throughout 26.5 million scientific articles, reveals unexplored and unpublished analysis areas, and delivers extra correct evaluation, drawing on 19 biomedical databases that includes 1000’s of sufferers.
Unique entry to cutting-edge spatial transcriptomic knowledge – It completely accesses and analyzes newly launched spatial multiomic knowledge at single cell decision from MOSAIC Window,³ a subset of the most important spatial omics dataset in oncology, offering researchers with insights and accuracy unmatched by every other AI co-pilot. MOSAIC knowledge is generated by prime tier tutorial universities throughout Europe and the US.
Superior efficiency – On duties associated to analyzing public datasets, Okay Navigator matches giant language fashions (together with reasoning fashions like 03 from OpenAI) and outperforms them in detecting cancer-related patterns.⁴
Free for the tutorial analysis neighborhood – Okay Navigator is free to tutorial researchers to strengthen the primary AI agentic biomedical collective intelligence. Owkin is working with world-leading establishments to form and repeatedly enhance it. The following replace of the product will embrace seamless collaboration, consequence sharing, and mission group, in addition to superior histology instruments for filtering, grouping, warmth mapping, and deeper digital pathology slide evaluation.
Reworking analysis past academia – Later this 12 months, Owkin will launch Okay Professional, an prolonged AI co-pilot that includes a collection of brokers to unravel complicated pharma challenges throughout knowledge exploration, drug discovery, and drug growth.
Thomas Clozel, MD, Owkin Co-founder and CEO, commented: “Over the previous century, we’ve made super progress in chemistry; progress that has solely accelerated with the assistance of AI. However biology is a special problem altogether: it’s too complicated for the human thoughts alone, with its huge networks of genes, cells, and interactions.
“To actually perceive illness and develop cures for unmet medical wants, we have to productize analysis by augmenting and accelerating discovery at each degree. That’s why we developed Okay Navigator. The final word intention for Okay is to curate giant language fashions and basis fashions with patient-level knowledge at scale, so we will transfer nearer to ground-truth biology and eventually seize its full complexity.”
Dr. Ingo Ringshausen, Principal Investigator at College School London & Guide Haematologist at College School London Hospital, stated, “After my first hands-on expertise with Okay Navigator, I used to be instantly struck by its distinctive ease of use. The potential influence for analysis groups is clear, specifically due to its sturdy multi-omics affected person knowledge exploration capabilities.”
Dr. Cécile Alanio, Deputy Director of Scientific Immunology Laboratory, Institut Curie, stated:“Okay Navigator is a tremendous product that provides us the autonomy we’ve been lacking to discover knowledge independently. It empowers researchers whereas enabling bioinformaticians to deal with extra complicated analytical challenges. The options are really spectacular, it permits us to get a really feel for the information – which is what I really like most about it.”
About Owkin
Owkin is an agentic AI firm on a mission to discover complicated biology to hurry up and scale analysis for the creation of recent therapies and diagnostics for sufferers. Owkin Okay, our AI co-pilot combines unparalleled entry to multimodal knowledge, cutting-edge AI to quantify biology and pioneering agentic AI to realize Organic Synthetic Superintelligence sooner or later.
References
- 20x productiveness is a median throughout numerous duties, for instance: producing a spatial transcriptomics plot takes on common 1 minute, in comparison with 3 days, and drug goal characterization (annotation) is on common 75% quicker with Okay in comparison with handbook strategies.
- Preliminary signup contains free entry to the beta model for a 6-month analysis interval. We’re at the moment restricted to a restricted variety of customers for the analysis interval of our beta model of Okay-Navigator. In the meanwhile, entry is out there to a small group of customers, and we’ve arrange a waitlist for everybody else serious about becoming a member of.
- MOSAIC is a worldwide initiative led by Owkin and uniting prime tutorial facilities (Charité – Universitätsmedizin Berlin, College of Pittsburgh, Institut Gustave Roussy, Lausanne College Hospital – CHUV, and Uniklinikum Erlangen), to create the world’s largest spatial omics and multimodal dataset in oncology and revolutionize therapeutic targets and biomarker discovery. MOSAIC Window is a 60-patient subset from the bigger MOSAIC dataset. This dataset is pseudonymized, pre-processed, and made out there to researchers via Okay Navigator.
- We benchmarked Okay-Navigator towards a subset of the general public benchmark LAB-Bench. On most duties, Okay-Navigator performs on par with all frontier LLMs examined, together with reasoning ones. Okay-Navigator reveals superiority on the oncogenic signature subtask. In oncogenic signature, fashions are requested to establish genes belonging to very particular gene units that behave in a sure manner in most cancers fashions.
Authorized discover
Sure potential customers of Owkin Okay could also be topic to anti-gift or anti-bribery laws primarily based on their career and jurisdiction. Owkin is accumulating all pertinent info from potential customers to make sure that anti-gifting and bribery legal guidelines are adopted throughout jurisdictions. Owkin reserves the precise to limit entry to sure customers who’re prohibited from accepting them underneath relevant laws.
Contacts
- Okay Navigator will increase researcher productiveness by 20x¹, accelerating biomedical breakthroughs and outperforming main generalist LLMs
- Analyzes and visualizes multimodal affected person knowledge, plus unique entry to MOSAIC Window, a subset of the world’s largest spatial omics dataset in oncology
- Constructed by biologists, for biologists. Free to make use of for educational researchers.²
NEW YORK & PARIS–(BUSINESS WIRE)–Owkin, a number one agentic AI firm, has launched Okay Navigator, an AI-powered analysis co-pilot designed to revolutionize biomedical science. Okay Navigator is an agentic playground the place researchers can discover, refine, and validate hypotheses, accelerating the standard and tempo of their discoveries. With Okay Navigator, Owkin strikes nearer to its imaginative and prescient of creating the world’s first Organic Synthetic Superintelligence (BASI).
Okay Navigator is an agentic AI playground the place researchers can discover, refine, and validate hypotheses, accelerating the standard and pace of their discoveries by 20X.
A single pure language interface – Okay Navigator allows customers to discover and visualize knowledge, refine questions, and uncover insights with ease. It accelerates literature critiques throughout 26.5 million scientific articles, reveals unexplored and unpublished analysis areas, and delivers extra correct evaluation, drawing on 19 biomedical databases that includes 1000’s of sufferers.
Unique entry to cutting-edge spatial transcriptomic knowledge – It completely accesses and analyzes newly launched spatial multiomic knowledge at single cell decision from MOSAIC Window,³ a subset of the most important spatial omics dataset in oncology, offering researchers with insights and accuracy unmatched by every other AI co-pilot. MOSAIC knowledge is generated by prime tier tutorial universities throughout Europe and the US.
Superior efficiency – On duties associated to analyzing public datasets, Okay Navigator matches giant language fashions (together with reasoning fashions like 03 from OpenAI) and outperforms them in detecting cancer-related patterns.⁴
Free for the tutorial analysis neighborhood – Okay Navigator is free to tutorial researchers to strengthen the primary AI agentic biomedical collective intelligence. Owkin is working with world-leading establishments to form and repeatedly enhance it. The following replace of the product will embrace seamless collaboration, consequence sharing, and mission group, in addition to superior histology instruments for filtering, grouping, warmth mapping, and deeper digital pathology slide evaluation.
Reworking analysis past academia – Later this 12 months, Owkin will launch Okay Professional, an prolonged AI co-pilot that includes a collection of brokers to unravel complicated pharma challenges throughout knowledge exploration, drug discovery, and drug growth.
Thomas Clozel, MD, Owkin Co-founder and CEO, commented: “Over the previous century, we’ve made super progress in chemistry; progress that has solely accelerated with the assistance of AI. However biology is a special problem altogether: it’s too complicated for the human thoughts alone, with its huge networks of genes, cells, and interactions.
“To actually perceive illness and develop cures for unmet medical wants, we have to productize analysis by augmenting and accelerating discovery at each degree. That’s why we developed Okay Navigator. The final word intention for Okay is to curate giant language fashions and basis fashions with patient-level knowledge at scale, so we will transfer nearer to ground-truth biology and eventually seize its full complexity.”
Dr. Ingo Ringshausen, Principal Investigator at College School London & Guide Haematologist at College School London Hospital, stated, “After my first hands-on expertise with Okay Navigator, I used to be instantly struck by its distinctive ease of use. The potential influence for analysis groups is clear, specifically due to its sturdy multi-omics affected person knowledge exploration capabilities.”
Dr. Cécile Alanio, Deputy Director of Scientific Immunology Laboratory, Institut Curie, stated:“Okay Navigator is a tremendous product that provides us the autonomy we’ve been lacking to discover knowledge independently. It empowers researchers whereas enabling bioinformaticians to deal with extra complicated analytical challenges. The options are really spectacular, it permits us to get a really feel for the information – which is what I really like most about it.”
About Owkin
Owkin is an agentic AI firm on a mission to discover complicated biology to hurry up and scale analysis for the creation of recent therapies and diagnostics for sufferers. Owkin Okay, our AI co-pilot combines unparalleled entry to multimodal knowledge, cutting-edge AI to quantify biology and pioneering agentic AI to realize Organic Synthetic Superintelligence sooner or later.
References
- 20x productiveness is a median throughout numerous duties, for instance: producing a spatial transcriptomics plot takes on common 1 minute, in comparison with 3 days, and drug goal characterization (annotation) is on common 75% quicker with Okay in comparison with handbook strategies.
- Preliminary signup contains free entry to the beta model for a 6-month analysis interval. We’re at the moment restricted to a restricted variety of customers for the analysis interval of our beta model of Okay-Navigator. In the meanwhile, entry is out there to a small group of customers, and we’ve arrange a waitlist for everybody else serious about becoming a member of.
- MOSAIC is a worldwide initiative led by Owkin and uniting prime tutorial facilities (Charité – Universitätsmedizin Berlin, College of Pittsburgh, Institut Gustave Roussy, Lausanne College Hospital – CHUV, and Uniklinikum Erlangen), to create the world’s largest spatial omics and multimodal dataset in oncology and revolutionize therapeutic targets and biomarker discovery. MOSAIC Window is a 60-patient subset from the bigger MOSAIC dataset. This dataset is pseudonymized, pre-processed, and made out there to researchers via Okay Navigator.
- We benchmarked Okay-Navigator towards a subset of the general public benchmark LAB-Bench. On most duties, Okay-Navigator performs on par with all frontier LLMs examined, together with reasoning ones. Okay-Navigator reveals superiority on the oncogenic signature subtask. In oncogenic signature, fashions are requested to establish genes belonging to very particular gene units that behave in a sure manner in most cancers fashions.
Authorized discover
Sure potential customers of Owkin Okay could also be topic to anti-gift or anti-bribery laws primarily based on their career and jurisdiction. Owkin is accumulating all pertinent info from potential customers to make sure that anti-gifting and bribery legal guidelines are adopted throughout jurisdictions. Owkin reserves the precise to limit entry to sure customers who’re prohibited from accepting them underneath relevant laws.
Contacts
- Okay Navigator will increase researcher productiveness by 20x¹, accelerating biomedical breakthroughs and outperforming main generalist LLMs
- Analyzes and visualizes multimodal affected person knowledge, plus unique entry to MOSAIC Window, a subset of the world’s largest spatial omics dataset in oncology
- Constructed by biologists, for biologists. Free to make use of for educational researchers.²
NEW YORK & PARIS–(BUSINESS WIRE)–Owkin, a number one agentic AI firm, has launched Okay Navigator, an AI-powered analysis co-pilot designed to revolutionize biomedical science. Okay Navigator is an agentic playground the place researchers can discover, refine, and validate hypotheses, accelerating the standard and tempo of their discoveries. With Okay Navigator, Owkin strikes nearer to its imaginative and prescient of creating the world’s first Organic Synthetic Superintelligence (BASI).
Okay Navigator is an agentic AI playground the place researchers can discover, refine, and validate hypotheses, accelerating the standard and pace of their discoveries by 20X.
A single pure language interface – Okay Navigator allows customers to discover and visualize knowledge, refine questions, and uncover insights with ease. It accelerates literature critiques throughout 26.5 million scientific articles, reveals unexplored and unpublished analysis areas, and delivers extra correct evaluation, drawing on 19 biomedical databases that includes 1000’s of sufferers.
Unique entry to cutting-edge spatial transcriptomic knowledge – It completely accesses and analyzes newly launched spatial multiomic knowledge at single cell decision from MOSAIC Window,³ a subset of the most important spatial omics dataset in oncology, offering researchers with insights and accuracy unmatched by every other AI co-pilot. MOSAIC knowledge is generated by prime tier tutorial universities throughout Europe and the US.
Superior efficiency – On duties associated to analyzing public datasets, Okay Navigator matches giant language fashions (together with reasoning fashions like 03 from OpenAI) and outperforms them in detecting cancer-related patterns.⁴
Free for the tutorial analysis neighborhood – Okay Navigator is free to tutorial researchers to strengthen the primary AI agentic biomedical collective intelligence. Owkin is working with world-leading establishments to form and repeatedly enhance it. The following replace of the product will embrace seamless collaboration, consequence sharing, and mission group, in addition to superior histology instruments for filtering, grouping, warmth mapping, and deeper digital pathology slide evaluation.
Reworking analysis past academia – Later this 12 months, Owkin will launch Okay Professional, an prolonged AI co-pilot that includes a collection of brokers to unravel complicated pharma challenges throughout knowledge exploration, drug discovery, and drug growth.
Thomas Clozel, MD, Owkin Co-founder and CEO, commented: “Over the previous century, we’ve made super progress in chemistry; progress that has solely accelerated with the assistance of AI. However biology is a special problem altogether: it’s too complicated for the human thoughts alone, with its huge networks of genes, cells, and interactions.
“To actually perceive illness and develop cures for unmet medical wants, we have to productize analysis by augmenting and accelerating discovery at each degree. That’s why we developed Okay Navigator. The final word intention for Okay is to curate giant language fashions and basis fashions with patient-level knowledge at scale, so we will transfer nearer to ground-truth biology and eventually seize its full complexity.”
Dr. Ingo Ringshausen, Principal Investigator at College School London & Guide Haematologist at College School London Hospital, stated, “After my first hands-on expertise with Okay Navigator, I used to be instantly struck by its distinctive ease of use. The potential influence for analysis groups is clear, specifically due to its sturdy multi-omics affected person knowledge exploration capabilities.”
Dr. Cécile Alanio, Deputy Director of Scientific Immunology Laboratory, Institut Curie, stated:“Okay Navigator is a tremendous product that provides us the autonomy we’ve been lacking to discover knowledge independently. It empowers researchers whereas enabling bioinformaticians to deal with extra complicated analytical challenges. The options are really spectacular, it permits us to get a really feel for the information – which is what I really like most about it.”
About Owkin
Owkin is an agentic AI firm on a mission to discover complicated biology to hurry up and scale analysis for the creation of recent therapies and diagnostics for sufferers. Owkin Okay, our AI co-pilot combines unparalleled entry to multimodal knowledge, cutting-edge AI to quantify biology and pioneering agentic AI to realize Organic Synthetic Superintelligence sooner or later.
References
- 20x productiveness is a median throughout numerous duties, for instance: producing a spatial transcriptomics plot takes on common 1 minute, in comparison with 3 days, and drug goal characterization (annotation) is on common 75% quicker with Okay in comparison with handbook strategies.
- Preliminary signup contains free entry to the beta model for a 6-month analysis interval. We’re at the moment restricted to a restricted variety of customers for the analysis interval of our beta model of Okay-Navigator. In the meanwhile, entry is out there to a small group of customers, and we’ve arrange a waitlist for everybody else serious about becoming a member of.
- MOSAIC is a worldwide initiative led by Owkin and uniting prime tutorial facilities (Charité – Universitätsmedizin Berlin, College of Pittsburgh, Institut Gustave Roussy, Lausanne College Hospital – CHUV, and Uniklinikum Erlangen), to create the world’s largest spatial omics and multimodal dataset in oncology and revolutionize therapeutic targets and biomarker discovery. MOSAIC Window is a 60-patient subset from the bigger MOSAIC dataset. This dataset is pseudonymized, pre-processed, and made out there to researchers via Okay Navigator.
- We benchmarked Okay-Navigator towards a subset of the general public benchmark LAB-Bench. On most duties, Okay-Navigator performs on par with all frontier LLMs examined, together with reasoning ones. Okay-Navigator reveals superiority on the oncogenic signature subtask. In oncogenic signature, fashions are requested to establish genes belonging to very particular gene units that behave in a sure manner in most cancers fashions.
Authorized discover
Sure potential customers of Owkin Okay could also be topic to anti-gift or anti-bribery laws primarily based on their career and jurisdiction. Owkin is accumulating all pertinent info from potential customers to make sure that anti-gifting and bribery legal guidelines are adopted throughout jurisdictions. Owkin reserves the precise to limit entry to sure customers who’re prohibited from accepting them underneath relevant laws.
Contacts
